Biosig Technologies (NASDAQ:STEX – Get Free Report) and Perspective Therapeutics (NASDAQ:CATX – Get Free Report) are both small-cap manufacturing companies, but which is the superior business? Analyst RecommendationsThis is a summary of recent ratings and target prices for Biosig Technologies and Perspective Therapeutics, as reported by MarketBeat. Given Perspective Therapeutics’ stronger consensus rating and higher possible upside, analysts clearly believe Perspective Therapeutics is more favorable than Biosig Technologies. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biosig Technologies $40,000.00 12,408.94 -$10.33 million ($1.35) -2.47 Perspective Therapeutics N/A N/A N/A ($0.90) -4.73Perspective Therapeutics has lower revenue, but higher earnings than Biosig Technologies. Net Margins Return on Equity Return on Assets Biosig Technologies N/A N/A -64.96% Perspective Therapeutics N/A N/A N/ASummaryPerspective Therapeutics beats Biosig Technologies on 6 of the 9 factors compared between the two stocks.